Μ‐Opioid Receptor Attenuates Aβ Oligomers‐Induced Neurotoxicity Through mTOR Signaling. (21st August 2014)
- Record Type:
- Journal Article
- Title:
- Μ‐Opioid Receptor Attenuates Aβ Oligomers‐Induced Neurotoxicity Through mTOR Signaling. (21st August 2014)
- Main Title:
- Μ‐Opioid Receptor Attenuates Aβ Oligomers‐Induced Neurotoxicity Through mTOR Signaling
- Authors:
- Wang, Yan
Wang, Yan‐Xia
Liu, Ting
Law, Ping‐Yee
Loh, Horace H.
Qiu, Yu
Chen, Hong‐Zhuan - Abstract:
- <abstract abstract-type="main" id="cns12316-abs-0001"> <title>Summary</title> <sec id="cns12316-sec-0001" sec-type="section"> <title>Aims</title> <p> <italic>μ</italic>‐opioid receptor (OPRM1) exerts many functions such as antinociception, neuroprotection, and hippocampal plasticity. A body of evidence has shown that OPRM1 activation could stimulate downstream effectors of mechanistic/mammalian target of rapamycin (mTOR). However, it is not clear whether OPRM1 protects neurons against <italic>β</italic>‐amyloid peptide (A<italic>β</italic>) neurotoxicity through mTOR signaling.</p> </sec> <sec id="cns12316-sec-0002" sec-type="section"> <title>Methods</title> <p>The effects of OPRM1 activation on A<italic>β</italic> oligomers‐induced neurotoxicity were assessed by cell viability and neurite outgrowth assay in primary cultured cortical neurons. The activities of mTOR, protein kinase B (Akt) and p70 ribosomal S6 kinase (p70 S6k) upon OPRM1 activation by morphine were measured by immunoblotting their phosphorylation status.</p> </sec> <sec id="cns12316-sec-0003" sec-type="section"> <title>Results</title> <p>Morphine dose‐dependently attenuated A<italic>β</italic> oligomers‐induced neurotoxicity. A<italic>β</italic> oligomers downregulated mTOR signaling. Morphine significantly rescued mTOR signaling by reversal of A<italic>β</italic> oligomers' effect on mTOR and its upstream signaling molecule Akt, as well as its downstream molecule p70 S6k. Moreover, the neuroprotective effect<abstract abstract-type="main" id="cns12316-abs-0001"> <title>Summary</title> <sec id="cns12316-sec-0001" sec-type="section"> <title>Aims</title> <p> <italic>μ</italic>‐opioid receptor (OPRM1) exerts many functions such as antinociception, neuroprotection, and hippocampal plasticity. A body of evidence has shown that OPRM1 activation could stimulate downstream effectors of mechanistic/mammalian target of rapamycin (mTOR). However, it is not clear whether OPRM1 protects neurons against <italic>β</italic>‐amyloid peptide (A<italic>β</italic>) neurotoxicity through mTOR signaling.</p> </sec> <sec id="cns12316-sec-0002" sec-type="section"> <title>Methods</title> <p>The effects of OPRM1 activation on A<italic>β</italic> oligomers‐induced neurotoxicity were assessed by cell viability and neurite outgrowth assay in primary cultured cortical neurons. The activities of mTOR, protein kinase B (Akt) and p70 ribosomal S6 kinase (p70 S6k) upon OPRM1 activation by morphine were measured by immunoblotting their phosphorylation status.</p> </sec> <sec id="cns12316-sec-0003" sec-type="section"> <title>Results</title> <p>Morphine dose‐dependently attenuated A<italic>β</italic> oligomers‐induced neurotoxicity. A<italic>β</italic> oligomers downregulated mTOR signaling. Morphine significantly rescued mTOR signaling by reversal of A<italic>β</italic> oligomers' effect on mTOR and its upstream signaling molecule Akt, as well as its downstream molecule p70 S6k. Moreover, the neuroprotective effect of morphine could be reversed by OPRM1 selective antagonist and phosphatidylinositol 3‐kinases (PI3K), Akt and mTOR inhibitors. Furthermore, endogenous opioids–enkaphalins also attenuated A<italic>β</italic> oligomers‐induced neurotoxicity.</p> </sec> <sec id="cns12316-sec-0004" sec-type="section"> <title>Conclusions</title> <p>Our findings demonstrated OPRM1 activation attenuated A<italic>β</italic> oligomers‐induced neurotoxicity through mTOR signaling. It may provide new insight into the pathological process and useful strategy for therapeutic interventions against A<italic>β</italic> neurotoxicity.</p> </sec> </abstract> … (more)
- Is Part Of:
- CNS neuroscience & therapeutics. Volume 21:Number 1(2015)
- Journal:
- CNS neuroscience & therapeutics
- Issue:
- Volume 21:Number 1(2015)
- Issue Display:
- Volume 21, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 21
- Issue:
- 1
- Issue Sort Value:
- 2015-0021-0001-0000
- Page Start:
- 8
- Page End:
- 14
- Publication Date:
- 2014-08-21
- Subjects:
- Neuropharmacology -- Periodicals
Central nervous system -- Diseases -- Effect of drugs on -- Periodicals
612.8 - Journal URLs:
- http://www.blackwell-synergy.com/loi/cnsnt ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cns.12316 ↗
- Languages:
- English
- ISSNs:
- 1755-5930
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.140000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3705.xml